These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28129942)

  • 1. Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use.
    Jarlenski M; Hogan C; Bogen DL; Chang JC; Bodnar LM; Van Nostrand E
    Womens Health Issues; 2017; 27(3):264-270. PubMed ID: 28129942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetric and Pediatric Provider Perspectives on Mandatory Reporting of Prenatal Substance Use.
    Jarlenski M; Minney S; Hogan C; Chang JC
    J Addict Med; 2019; 13(4):258-263. PubMed ID: 30550393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national survey of state maternal and newborn drug testing and reporting policies.
    Adirim TA; Sen Gupta N
    Public Health Rep; 1991; 106(3):292-6. PubMed ID: 1905050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Implementation of State and Federal Child Welfare Laws Related to Drug Use in Pregnancy.
    McCOURT AD; White SA; Bandara S; Schall T; Goodman DJ; Patel E; McGINTY EE
    Milbank Q; 2022 Dec; 100(4):1076-1120. PubMed ID: 36510665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah.
    Bandara S; Schall TE; White SA; McCourt AD; Goodman D; McGinty EE
    Int J Drug Policy; 2022 Oct; 108():103806. PubMed ID: 35907372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnant Women with Substance Use Disorders - The Harm Associated with Punitive Approaches.
    Haffajee RL; Faherty LJ; Zivin K
    N Engl J Med; 2021 Jun; 384(25):2364-2367. PubMed ID: 34161722
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy.
    Austin AE; Naumann RB; Simmons E
    JAMA Pediatr; 2022 Nov; 176(11):1123-1130. PubMed ID: 36121649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.
    Faherty LJ; Kranz AM; Russell-Fritch J; Patrick SW; Cantor J; Stein BD
    JAMA Netw Open; 2019 Nov; 2(11):e1914078. PubMed ID: 31722022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women.
    Angelotta C; Weiss CJ; Angelotta JW; Friedman RA
    Womens Health Issues; 2016; 26(6):595-601. PubMed ID: 27773527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018.
    Patel E; Bandara S; Saloner B; Stuart EA; Goodman D; Terplan M; McCourt A; White S; McGinty EE
    Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100419. PubMed ID: 34116233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State Policies Targeting Alcohol Use during Pregnancy and Alcohol Use among Pregnant Women 1985-2016: Evidence from the Behavioral Risk Factor Surveillance System.
    Roberts SCM; Mericle AA; Subbaraman MS; Thomas S; Treffers RD; Delucchi KL; Kerr WC
    Womens Health Issues; 2019; 29(3):213-221. PubMed ID: 30876695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State Laws on Substance Use Treatment for Incarcerated Pregnant and Postpartum People.
    Steely Smith MK; Zielinski MJ; Sufrin C; Kramer CT; Benning SJ; Laine R; Shlafer RJ
    Subst Abuse; 2023; 17():11782218231195556. PubMed ID: 37746631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A search for guidance: examining prenatal substance exposure protocols.
    Zellman GL; Fair C; Houbé J; Wong M
    Matern Child Health J; 2002 Sep; 6(3):205-12. PubMed ID: 12236668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal substance abuse and human subjects research: are privacy protections adequate?
    Marshall MF; Menikoff J; Paltrow LM
    Ment Retard Dev Disabil Res Rev; 2003; 9(1):54-9. PubMed ID: 12587139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive health and blurred professional boundaries.
    Chavkin W; Breitbart V
    Womens Health Issues; 1996; 6(2):89-96. PubMed ID: 8932462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of State Perinatal Hepatitis B Prevention Laws.
    Culp LA; Caucci L; Fenlon NE; Lindley MC; Nelson NP; Murphy TV
    Am J Prev Med; 2016 Dec; 51(6):e179-e185. PubMed ID: 27866601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of State Laws Giving Pregnant People Priority Access to Drug Treatment Programs in the Context of Coexisting Punitive Laws.
    White SA; McCourt A; Bandara S; Goodman DJ; Patel E; McGinty EE
    Womens Health Issues; 2023; 33(2):117-125. PubMed ID: 36272928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database.
    Kozhimannil KB; Dowd WN; Ali MM; Novak P; Chen J
    Addict Behav; 2019 Mar; 90():272-277. PubMed ID: 30472535
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Thomas KA; Struble CA; Stenersen MR; Moore K
    J Law Med Ethics; 2024; 52(S1):75-80. PubMed ID: 38995261
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.